News & Views

Responding to the government's 10 Year Health Plan for England, which was published today, College President Professor Ben Burton said: “The 10 Year Health Plan marks an important step toward a more sustainable NHS. We welcome the recognition of ophthalmology as a priority specialty in outpatient redesign and the commitment to expanding specialty training with 1,000 new posts. While shifting care closer to home is welcome where appropriate, detail is needed about how this will be funded. We look forward to working with the government and other partners to ensure that ophthalmology services are future-proofed and deliver the highest standards of patient care.”

Read our latest policy roundup, a series of advocacy updates on our most recent policy and public affairs activities and successes.

A research team from Moorfields, led by Mr Harry Petrushkin, has launched a new national study through the British Ophthalmological Surveillance Unit (BOSU) into ocular hypotony, a sight-threatening condition where the pressure inside the eye is low enough for long enough to cause permanent structural changes and vision loss.

This blog post unpacks where we stand with practical and safe AI adoption in ophthalmology, why a credible AI directory helps, and where AI innovation may take us next.

The College has pledged its commitment to the #SASsix campaign, a national initiative aimed at supporting specialist, associate specialist and specialty (SAS) doctors to develop within their careers and become leaders and educators. SAS doctors and locally employed doctors (LEDs) are the most rapidly rising group of doctors on the medical register.

Dr Ana Pueyo-Bestué of Miguel Servantes Hospital in Zaragoza, Spain and Dr Toshit Varshni of Save Sight Centre Eye Hospital, Delhi, India, have been announced as the joint winners of the 2024 Chandra Awards.

The College has responded to the government's Spending Review, which was published yesterday (11 June).

The College welcomes NHS England's new guidance for treating wet age-related macular degeneration (wAMD). This consensus-based pathway aims to optimise treatment while expanding use of more cost-effective medicines within the NHS.

Read our latest policy roundup, a series of advocacy updates on our most recent policy and public affairs activities and successes.